Editorials

Use of chloramphenicol as topical eye medication: time to cry halt?

Chloramphenicol accounts for over half the general medical services prescriptions for ocular antibiotics in the Republic of Ireland, while in the United Kingdom 55% of patients presenting to general practitioners with "red eyes" are treated with chloramphenicol eye ointment.¹ The British National Formulary currently recommends chloramphenicol as the drug of choice for superficial eye infections. It has the advantage that it has a broad spectrum of activity and rarely causes local irritation or hypersensitivity, which may be a problem with other antibiotics. Yet on our wards we no longer prescribe topical ocular chloramphenicol. Why?

Since 1950, when Rich et al highlighted the relation between oral chloramphenicol and bone marrow aplasia,² doctors have been well aware of this side effect. The first death resulting from bone marrow aplasia induced by chloramphenicol eye drops was described by Rosenthal and Blackman in 1955.³ Numerous subsequent . . . [Full text of this article]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Articles

Is it time to stop using chloramphenicol on the eye?

R J Mulla, E Barnes, and T R Rogers
BMJ 1995 311: 450. [Extract] [Full Text]

Safe in patients with no history of blood dyscrasia

R J K Buckley, C M Kirkness, J J Kanski, A E A Ridgway, A B Tullo, and P G Watson
BMJ 1995 311: 450. [Extract] [Full Text]

Risk is low in short courses

A V Hall, S S Das, and S Tabaqchali
BMJ 1995 311: 450-451. [Extract] [Full Text]

General practitioners would expect to see aplasia roughly once each century

Jim Cox and Eleri M Roderick
BMJ 1995 311: 451. [Extract] [Full Text]

Prospective study of aplastic anaemia should give definitive answer

E C Gordon-Smith, J C W Marsh, and C G Geary
BMJ 1995 311: 451. [Extract] [Full Text]

This article has been cited by other articles:

• Sahu, D N, Thomson, S, Salam, A, Morton, G, Hodgkins, P (2006). Neonatal methicillin resistant Staphylococcus aureus conjunctivitis. Br. J. Ophthalmol. 90: 794-795 [Full text]  
• Leibowitz, H. M. (2000). The Red Eye. NEJM 343: 345-351 [Full text]  
• Wiholm, B.-E., Kelly, J. P., Kaufman, D., Issaragrisil, S., Levy, M., Anderson, T., Shapiro, S. (1998). Relation of aplastic anaemia to use of chloramphenicol eye drops in two international case-control studies. BMJ 316: 666-666 [Full text]  
• Lancaster, T., Swart, A. M., Jick, H. (1998). Risk of serious haematological toxicity with use of chloramphenicol eye drops in a British general practice database. BMJ 316: 667-667 [Full text]